NEW YORK, April 3, 2017 /PRNewswire/ --
FinancialBuzz.com News Commentary
A major submarket of the legal cannabis industry is Cannabidiol (CBD). CBD is the part of the plant that is not associated with the side effects of THC, so therefore CBD is usually used for medical reasons and not reactional purposes. A report by The Hemp Business Journal projects that the CBD market will reach $2.1 billion in consumer sales by 2020, with $450 million of those sales coming from hemp-based sources. The report reveals that in 2015, the market for hemp-derived CBD products was worth $90 million. The addition of the $112 million in marijuana-derived CBD products were sold through dispensaries and the total CBD market was worth $202 million in 2015. ChineseInvestors.com, Inc. (OTC: CIIX), Medicine Man Technologies Inc. (OTC: MDCL), CV Sciences, Inc. (OTC: CVSI), Cannabis Sativa, Inc. (OTC: CBDS), Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)
Others have similar or more optimistic estimates about the industry's future. Matt Karnes from Greenwave Advisors stated, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only - this is in addition to the 28 states plus DC that have legalized medical marijuana." A report by Forbes points out there is evidence that traditional cannabis users are willing to give CBD a try. Outco, the largest licensed cultivator in Southern California published data that shows 38% of users and non-users claimed they wanted to learn more about CBD oil.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is a premier financial information website for Chinese-speaking investors. On March 30th the company announced its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company. Building on the success that CIIX enjoyed through its investment in early-stage firm Medicine Man Technologies, the Company is pleased to announce another strategic investment in the cannabis industry.
Breakwater MB was formed by CIIX board member and former CFO Paul Dickman as a means to invest capital in and provide consulting services to private, cannabis-focused companies as they transition into the public market. The invested capital will primarily be used to cover the costs of becoming a publicly-traded company, a strategy CIIX expects will provide significant investment appreciation and opportunity for liquidity. All opportunities will be evaluated by the investment committee comprised of CIIX CEO Warren Wang, Medicine Man Technologies Inc. (OTCQB: MDCL) CEO Andy Williams, and Paul Dickman, the CFO of Medicine Man and managing member of Breakwater MB.
"By focusing on these transitional phase investments, it's our expectation that investors in Breakwater MB will enjoy significant capital appreciation in its investment due to the arbitrage in value between private and public companies, the growth through access to the capital markets, the firm's expertise and established network, as well as short-term liquidity due to investing in newly formed publicly traded companies," states Dickman.
CV Sciences, Inc. (OTCQB: CVSI) is a supplier and manufacturer of hemp-derived CBD oil. The company recently announced its industry dominating brand of hemp-derived CBD oil finished products; PlusCBD Oil™ will be exhibiting at Natural Products Expo West on March 9-12, in Anaheim, California. Produced by New Hope Network, Natural Products Expo West is one of the world's leading trade shows in the natural, organic and healthy products industry attracting over 77,000 industry professionals and 3,000 exhibits to the Anaheim Convention Center. "As the preeminent leaders in hemp-derived CBD, we believe it is our obligation to create products that retailers can count on," stated Stuart Tomc, VP of Human Nutrition and spokesperson at CV Sciences. "PlusCBD Oil™ has been driving the growth of this newly emerging category due to the consistency, efficacy, and safety profile of our products. We are pleased to report that PlusCBD Oil™ is now available in over 1000 health food stores and counting, and we truly have our retailer partners to thank for joining the CBD Evolution - many of whom have been with us since our first Expo West two years ago."
Cannabis Sativa, Inc. (OTCQB: CBDS) develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company announced that on December 20, 2016, the company's subsidiary was awarded Patent PP27,475 for a Cannabis Plant named Ecuadorian Sativa and deemed "CTA". Equadorian Sativa has been shown in laboratory testing by Steephill Labs to have a Limonene level that is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets Equadorian Sativa apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases. Earlier in January, the company announced that the European Commission has granted Orphan Designation in the European Union ("EU") for the Company's novel synthetic oral endocannabinoid-mimetic drug, JBT-101 ("Resunab") for the treatment of systemic sclerosis. A main endocannabinoid is 2-Arachidonoylglycerol (2-AG) which is active at both cannabinoid receptors, along with its own mimetic phytocannabinoid, CBD. 2-AG and CBD are involved in the regulation of appetite, immune system functions and pain management.
Please sign up now at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially-driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact: email@example.com